About - aids.about.com
General Information:
Latest News:
A Few Facts About the New Alere™ Rapid HIV Test 27 Aug 2013 | 03:04 pm
When the U.S. Food and Drug Administration (FDA) approved the Alere Determine HIV-1/2 AG Combo™ test on August 8, we were among those pleased to hear the news. It's not that we don't already have poin...
Meet the GOP Boss Who Doubts That HIV is Real 27 Aug 2013 | 12:08 pm
If there was any doubt that HIV denialism was still alive and kicking, all one would need do is turn to the Oregon Republican Party and its newly elected chair for proof. Arthur B. "Art" Robinson, a b...
Tivacay Wholesale Price Raises Questions, Concerns 19 Aug 2013 | 03:45 pm
When Tivacay (dolutegravir) was approved by U.S. Food and Drug Administration (FDA) on August 12, we were among many who applauded its arrival and heralded its virtues. However, the one issue we noted...
FDA Approves GlaxoSmithKline's New HIV Drug, Tivicay 13 Aug 2013 | 04:34 pm
GlaxoSmithKline's long-awaited integrase inhibitor-class drug, Ticivay (dolutegravir), received approval on Monday from the U.S. Food and Drug Administration. The once-daily HIV treatment is the third...
New Post-Exposure Prophylaxis (PEP) Guidelines for Healthcare Personnel 13 Aug 2013 | 10:40 am
The U.S. Public Health Service (USPHS) updated its post-exposure prophylaxis (PEP) guidelines with regards to occupational exposure to HIV among healthcare personnel. The new guidelines, released on A...
FDA to Speed Regulatory Approval of HIV, Cancer Drugs 13 Aug 2013 | 09:48 am
One of the greatest challenges facing an aging HIV population is the diminishing treatment options for people who have been on combination antiretroviral therapy (cART) for 20 or more years. Naturally...
10 Tips for Donating to HIV/AIDS Charities 6 Aug 2013 | 03:12 pm
There is no question that, as a whole, America has a culture of charitable giving. According to the Center on Philanthropy at Indiana University, 88% of U.S. households give to charity each year at a ...
Might PrEP Lead to Lower Condom Use? 31 Jul 2013 | 12:32 pm
Since the U.S. Centers for Disease Control and Prevention (CDC) first released interim guidance on the use of PrEP (or pre-exposure prophylaxis) in reducing the risk of HIV infection through unprotect...
Lower-Dose Sustiva Equally Effective in First-Line Therapy 24 Jul 2013 | 12:24 pm
One of the most frequent challenges associated with the drug Sustiva (efavirenz) is the sometimes unsteadying effect it has on the central nervous system. These side effects can include dizziness, ins...
Why Does U.S. HIV Infection Rate Stagnate as African Rates Plummet? 16 Jul 2013 | 08:13 am
President Obama's recent tour of Africa highlighted a glaringly obvious contradiction between the effectiveness of U.S. domestic HIV/AIDS policy versus that of the hardest hit African countries. Why h...
